Scientific article
Evaluation of Macitentan in Patients With Eisenmenger Syndrome: Results From the Randomized, Controlled MAESTRO Study
ContributorsGatzoulis, Michael A; Landzberg, Michael; Beghetti, Maurice; Berger, Rolf M; Efficace, Michela; Gesang, Sophie; He, Jian'guo; Papadakis, Kelly; Pulido, Tomás; Galiè, Nazzareno; MAESTRO Study Investigators
Published inCirculation, vol. 139, no. 1, p. 51-63
Publication date2019
Abstract
Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antihypertensive Agents/adverse effects/therapeutic use
- Biomarkers/blood
- Child
- Double-Blind Method
- Down Syndrome/complications
- Eisenmenger Complex/complications/diagnostic imaging/physiopathology
- Endothelin Receptor Antagonists/adverse effects/therapeutic use
- Exercise Tolerance/drug effects
- Female
- Hemodynamics/drug effects
- Humans
- Hypertension, Pulmonary/diagnostic imaging/drug therapy/etiology/physiopathology
- Male
- Middle Aged
- Natriuretic Peptide, Brain/blood
- Peptide Fragments/blood
- Pulmonary Artery/drug effects/physiopathology
- Pyrimidines/adverse effects/therapeutic use
- Recovery of Function
- Sulfonamides/adverse effects/therapeutic use
- Time Factors
- Treatment Outcome
- Walk Test
- Young Adult
Affiliation entities
Research groups
Citation (ISO format)
GATZOULIS, Michael A et al. Evaluation of Macitentan in Patients With Eisenmenger Syndrome: Results From the Randomized, Controlled MAESTRO Study. In: Circulation, 2019, vol. 139, n° 1, p. 51–63. doi: 10.1161/CIRCULATIONAHA.118.033575
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:134639
- DOI : 10.1161/CIRCULATIONAHA.118.033575
- PMID : 30586694
Additional URL for this publicationhttps://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.033575
Journal ISSN0009-7322
